Literature DB >> 11748792

Psychotropics and drug interactions in the elderly patient.

C L Katona1.   

Abstract

This short paper attempts to provide a framework to aid the old-age psychiatrist in choosing psychotropic drugs in a way that minimizes the risks of adverse drug reactions. It concentrates on the clinical problems most frequently encountered in old-age psychiatric practice. Older people are at risk of adverse drug interactions because of their higher rate of physical morbidity and increased likelihood of receiving polypharmacy, as well as due to age-related change in drug handling. The strongest evidence for relevant interactions in older people relates to changes in renal excretion (particularly relevant for lithium) and cytochrome P450 (relevant for a wide range of psychotropic and other drugs). Awareness of potential interactions is important in ensuring safe prescribing practice for older people with mental health problems. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748792     DOI: 10.1002/1099-1166(200112)16:1+<::aid-gps564>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  7 in total

1.  Using drama to improve person-centred dementia care.

Authors:  Pia C Kontos; Gail J Mitchell; Bhavnita Mistry; Bruce Ballon
Journal:  Int J Older People Nurs       Date:  2010-06       Impact factor: 2.115

2.  Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status.

Authors:  Ing-Britt Holmquist; Bengt Svensson; Peter Höglund
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

Review 3.  Neuromodulation therapies for geriatric depression.

Authors:  Verònica Gálvez; Kerrie-Anne Ho; Angelo Alonzo; Donel Martin; Duncan George; Colleen K Loo
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

4.  Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011.

Authors:  Anna K Holl; Renate Grohmann; Martin Letmaier; Annamaria Painold; Sabrina Mörkl; Sermin Toto; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-20       Impact factor: 5.270

5.  Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-label study.

Authors:  Keith Edwards; Barbara Koumaras; Michael Chen; Ibrahim Gunay; Dario Mirski
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards.

Authors:  S J C Davies; S Eayrs; P Pratt; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

7.  Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.

Authors:  Charles Timäus; Jonathan Vogelgsang; Bernhard Kis; Katrin Radenbach; Claus Wolff-Menzler; Kiriaki Mavridou; Stephan Gyßer; Philipp Hessmann; Jens Wiltfang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-01-29       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.